Back
Essent Group 10K Form
Buy
75
ESNT
Essent Group
Last Price:
53.43
Seasonality Move:
6.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-07 | 10Q | ESNT/Essent Group Quarterly |
| 2023-08-08 | 10Q | ESNT/Essent Group Quarterly |
| 2023-05-10 | 10Q | ESNT/Essent Group Quarterly |
| 2022-11-08 | 10Q | ESNT/Essent Group Quarterly |
| 2022-08-08 | 10Q | ESNT/Essent Group Quarterly |
| 2022-05-06 | 10Q | ESNT/Essent Group Quarterly |
Receive ESNT News And Ratings
See the #1 stock for the next 7 days that we like better than ESNT
ESNT Financial Statistics
Sales & Book Value
| Annual Sales: | $1.12B |
|---|---|
| Cash Flow: | $213.29M |
| Price / Cash Flow: | 7.55 |
| Annual Sales: | $47.87 |
| Price / Book: | 1.12 |
Profitability
| EPS (TTM): | 6.50000 |
|---|---|
| Net Income (TTM): | $696.39M |
| Gross Margin: | $0 |
| Return on Equity: | 14.66% |
| Return on Assets: | 11.55% |
Essent Group Earnings Forecast
Key Essent Group Financial Ratios
- The Gross Profit Margin over the past 4 years for ESNT is 0.00%.
- The Selling, General & Administrative Expenses for ESNT have been equal to 10.25% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 4.33% of Operating Income.
- The Net Earning history of ESNT is 62.13% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 10 years.
Essent Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Financial Services |
| Sector: | Financials |
| Current Symbol: | ESNT |
| CUSIP: | G3198U |
| Website: | ir.essentgroup.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 10.59 |
| Quick Ratio: | 9.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.22 |
|---|---|
| Forward P/E Ratio: | 7.58 |
ESNT Technical Analysis vs Fundamental Analysis
Buy
75
Essent Group (ESNT)
is a Buy
Is Essent Group a Buy or a Sell?
-
Essent Group stock is rated a Buy
The current Essent Group [ESNT] share price is $53.46. The Score for ESNT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.